Literature DB >> 10196329

Functional anatomy of herpes simplex virus 1 overlapping genes encoding infected-cell protein 22 and US1.5 protein.

W O Ogle1, B Roizman.   

Abstract

Earlier studies have shown that (i) the coding domain of the alpha22 gene encodes two proteins, the 420-amino-acid infected-cell protein 22 (ICP22) and a protein, US1.5, which is initiated from methionine 147 of ICP22 and which is colinear with the remaining portion of that protein; (ii) posttranslational processing of ICP22 mediated largely by the viral protein kinase UL13 yields several isoforms differing in electrophoretic mobility; and (iii) mutants lacking the carboxyl-terminal half of the ICP22 and therefore DeltaUS1.5 are avirulent and fail to express normal levels of subsets of both alpha (e.g., ICP0) or gamma2 (e.g., US11 and UL38) proteins. We have generated and analyzed two sets of recombinant viruses. The first lacked portions of or all of the sequences expressed solely by ICP22. The second set lacked 10 to 40 3'-terminal codons of ICP22 and US1. 5. The results were as follows. (i) In cells infected with mutants lacking amino-terminal sequences, translation initiation begins at methionine 147. The resulting protein cannot be differentiated in mobility from authentic US1.5, and its posttranslational processing is mediated by the UL13 protein kinase. (ii) Expression of US11 and UL38 genes by mutants carrying only the US1.5 gene is similar to that of wild-type parent virus. (iii) Mutants which express only US1. 5 protein are avirulent in mice. (iv) The coding sequences Met147 to Met171 are essential for posttranslational processing of the US1.5 protein. (v) ICP22 made by mutants lacking 15 or fewer of the 3'-terminal codons are posttranslationally processed whereas those lacking 18 or more codons are not processed. (vi) Wild-type and mutant ICP22 proteins localized in both nucleus and cytoplasm irrespective of posttranslational processing. We conclude that ICP22 encodes two sets of functions, one in the amino terminus unique to ICP22 and one shared by ICP22 and US1.5. These functions are required for viral replication in experimental animals. US1.5 protein must be posttranslationally modified by the UL13 protein kinase to enable expression of a subset of late genes exemplified by UL38 and US11. Posttranslational processing is determined by two sets of sequences, at the amino terminus and at the carboxyl terminus of US1.5, respectively, a finding consistent with the hypothesis that both domains interact with protein partners for specific functions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196329      PMCID: PMC104212     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides.

Authors:  R W Honess; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

3.  Structures of two spliced herpes simplex virus type 1 immediate-early mRNA's which map at the junctions of the unique and reiterated regions of the virus DNA S component.

Authors:  R J Watson; M Sullivan; G F Vande Woude
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

4.  A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth.

Authors:  L E Post; B Roizman
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

5.  Detailed structural analysis of two spliced HSV-1 immediate-early mRNAs.

Authors:  F J Rixon; J B Clements
Journal:  Nucleic Acids Res       Date:  1982-04-10       Impact factor: 16.971

6.  A novel cellular protein, p60, interacting with both herpes simplex virus 1 regulatory proteins ICP22 and ICP0 is modified in a cell-type-specific manner and Is recruited to the nucleus after infection.

Authors:  R Bruni; B Fineschi; W O Ogle; B Roizman
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  Expression of immediate-early genes in herpes simplex virus type 1-infected XC cells: lack of ICP22 (68K) polypeptide.

Authors:  B Jacquemont; B Verrier; A L Epstein; I Machuca
Journal:  J Gen Virol       Date:  1984-08       Impact factor: 3.891

8.  Herpes simplex virus 1 mutant deleted in the alpha 22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice.

Authors:  A E Sears; I W Halliburton; B Meignier; S Silver; B Roizman
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

9.  Application of antibody to synthetic peptides for characterization of the intact and truncated alpha 22 protein specified by herpes simplex virus 1 and the R325 alpha 22- deletion mutant.

Authors:  M Ackermann; M Sarmiento; B Roizman
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

10.  Regulation of herpesvirus macromolecular synthesis: transcription-initiation sites and domains of alpha genes.

Authors:  S Mackem; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  41 in total

1.  Small dense nuclear bodies are the site of localization of herpes simplex virus 1 U(L)3 and U(L)4 proteins and of ICP22 only when the latter protein is present.

Authors:  N S Markovitz; B Roizman
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a herpes simplex virus 1 mutant lacking intact genes expressing both glycoproteins.

Authors:  G Zhou; V Galvan; G Campadelli-Fiume; B Roizman
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Posttranslational processing of infected cell proteins 0 and 4 of herpes simplex virus 1 is sequential and reflects the subcellular compartment in which the proteins localize.

Authors:  S J Advani; R Hagglund; R R Weichselbaum; B Roizman
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  The role of cdc2 in the expression of herpes simplex virus genes.

Authors:  S J Advani; R R Weichselbaum; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

Review 5.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

6.  Sequence variation in the herpes simplex virus U(S)1 ocular virulence determinant.

Authors:  Aaron W Kolb; Timothy R Schmidt; David W Dyer; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-28       Impact factor: 4.799

Review 7.  Peculiarities of herpes simplex virus (HSV) transcription: an overview.

Authors:  Július Rajcáni; Vojvodová Andrea; Rezuchová Ingeborg
Journal:  Virus Genes       Date:  2004-04       Impact factor: 2.332

8.  A truncation mutation of the neurovirulence ICP22 protein produced by a recombinant HSV-1 generated by bacterial artificial chromosome technology targets infected cell nuclei.

Authors:  Robert N Bowles; John A Blaho
Journal:  J Neurovirol       Date:  2011-12-03       Impact factor: 2.643

9.  The disappearance of cyclins A and B and the increase in activity of the G(2)/M-phase cellular kinase cdc2 in herpes simplex virus 1-infected cells require expression of the alpha22/U(S)1.5 and U(L)13 viral genes.

Authors:  S J Advani; R Brandimarti; R R Weichselbaum; B Roizman
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

10.  ICP0 gene expression is a herpes simplex virus type 1 apoptotic trigger.

Authors:  Christine M Sanfilippo; John A Blaho
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.